TERAZOSIN

Product NDC: 51655-676
11-digit product format: 516550676
Labeler code: 51655
Product ID: 51655-676_3a44b1b3-4d38-4347-8524-20445e2f0b8d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: terazosin hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: Northwind Pharmaceuticals, LLC
Application: ANDA075317
Marketing category: ANDA
Marketing start: 2015-02-27
Marketing end: 0000-00-00
Substance: TERAZOSIN HYDROCHLORIDE
Active strength: 5 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-676-52	2026-01-02	C162847	48780-1	9d75b9d0-de1f-f424-e053-dadaa90a57ce	3109caa1-3388-41b4-ab9a-aee009c7326d
51655-676-52	2020-01-31	C162847	48780-1	9d75b9d0-de1f-f424-e053-dadaa90a57ce	3109caa1-3388-41b4-ab9a-aee009c7326d

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
TERAZOSIN HYDROCHLORIDE	ACTIVE INGREDIENT	D32S14F082	TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [NORTHWIND PHARMACEUTICALS, LLC]	1
TERAZOSIN	ACTIVE MOIETY	8L5014XET7	TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [NORTHWIND PHARMACEUTICALS, LLC]	1

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-676	TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [NORTHWIND PHARMACEUTICALS, LLC]	1	Legacy NDC	20150320_3109caa1-3388-41b4-ab9a-aee009c7326d.zip